Howarth Alex's most recent trade in Madrigal Pharmaceuticals Inc was a trade of 7,238 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 23, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Madrigal Pharmaceuticals Inc | Howarth Alex | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 7,238 | 7,238 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharmaceuticals Inc | Alex Howarth | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 4,803 | 4,803 | - | - | Market Stock Unit | |
| Madrigal Pharmaceuticals Inc | Alex Howarth | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 4,803 | 18,737 (0%) | 0% | 0 | Common Stock | |
| Madrigal Pharmaceuticals Inc | Alex Howarth | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 243.92 per share. | 16 Jan 2024 | 1,067 | 13,934 (0%) | 0% | 243.9 | 260,263 | Common Stock |
| Madrigal Pharmaceuticals Inc | Alex Howarth | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2023 | 15,001 | 15,001 (0%) | 0% | 0 | Common Stock | |
| Madrigal Pharmaceuticals Inc | Alex Howarth | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharmaceuticals Inc | Alex Howarth | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2021 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) |